MyAverix Finance
US · Healthcare
Imunon Inc (IMNN)
Biotechnology
Imunon Inc (IMNN) is listed on US in the Healthcare sector. Industry: Biotechnology. As of 2026-05-23, reported P/E ratio is 25.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for IMNN
P/E ratio
25.00
Imunon Inc (IMNN) — FAQ
What is IMNN's P/E ratio?
The price-to-earnings (P/E) ratio for Imunon Inc (IMNN) is 25.00 (data as of 2026-05-23).
Does Imunon Inc pay a dividend?
Dividend yield is not available in the current snapshot for Imunon Inc (IMNN). Check the MyAverix Finance app for the latest dividend data.
What sector is Imunon Inc in?
Imunon Inc (IMNN) is classified in the Healthcare sector (Biotechnology industry).
What exchange is IMNN listed on?
IMNN is listed on US.
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.